Abstract:Fragile X syndrome is an inheritable form of intellectual disability caused by loss of fragile X mental retardation protein (FMRP, encoded by the FMR1 gene). Absence of FMRP caused overexpression of progranulin (PGRN, encoded by GRN), a putative tumour necrosis factor receptor ligand. In the present study, we found that progranulin mRNA and protein were upregulated in the medial prefrontal cortex of Fmr1 knock-out mice. In Fmr1 knock-out mice, elevated progranulin caused insufficient dendritic spine pruning and late-phase long-term potentiation in the medial prefrontal cortex of Fmr1 knock-out mice. Partial progranulin knock-down restored spine morphology and reversed behavioural deficits, including impaired fear memory, hyperactivity, and motor inflexibility in Fmr1 knock-out mice. Progranulin increased levels of phosphorylated glutamate ionotropic receptor GluA1 and nuclear factor kappa B in cultured wild-type neurons. Tumour necrosis factor receptor 2 antibody perfusion blocked the effects of progranulin on GluA1 phosphorylation; this result indicates that tumour necrosis factor receptor 2 is required for progranulin-mediated GluA1 phosphorylation and late-phase long-term potentiation expression. However, high basal level of progranulin in Fmr1 knock-out mice prevented further facilitation of synaptic plasticity by exogenous progranulin. Partial downregulation of progranulin or tumour necrosis factor receptor 2/nuclear factor kappa B signalling restored synaptic plasticity and memory deficits in Fmr1 knock-out mice. These findings suggest that elevated PGRN is linked to cognitive deficits of fragile X syndrome, and the progranulin/tumour necrosis factor receptor 2 signalling pathway may be a putative therapeutic target for improving cognitive deficits in fragile X syndrome.

Regulation of GABAA Receptors by Fragile X Mental Retardation Protein.

GABAB Receptor Upregulates Fragile X Mental Retardation Protein Expression in Neurons

Fragile X Mental Retardation Protein is Required for Chemically‐induced Long‐term Potentiation of the Hippocampus in Adult Mice

Increased Coupling Of Caveolin-1 And Estrogen Receptor Alpha Contributes To The Fragile X Syndrome

FMRP Acts As a Key Messenger for Dopamine Modulation in the Forebrain

Activity-Dependent Regulation of Release Probability at Excitatory Hippocampal Synapses: A Crucial Role of Fragile X Mental Retardation Protein in Neurotransmission

Impaired GABA Neural Circuits Are Critical for Fragile X Syndrome

Modeling Fragile X Syndrome: Characterizing Fmr1 Gene Knockout Mice across Genotype, Behavior, and Morphology

Ras Signaling Mechanisms Underlying Impaired GluR1-Dependent Plasticity Associated with Fragile X Syndrome

Fragile X Mental Retardation Protein Modulates the Stability of Its M6a-Marked Messenger RNA Targets.

Fragile X Proteins FMRP and FXR2P Control Synaptic GluA1 Expression and Neuronal Maturation Via Distinct Mechanisms

Fragile X Mental Retardation Protein Regulates Proliferation and Differentiation of Adult Neural Stem/Progenitor Cells

Fmr1 Deficiency Promotes Age-Dependent Alterations In The Cortical Synaptic Proteome

Enhanced Endocannabinoid Signaling Elevates Neuronal Excitability In Fragile X Syndrome

New perspectives on the biology of fragile X syndrome.

The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome

Elevated Progranulin Contributes to Synaptic and Learning Deficit Due to Loss of Fragile X Mental Retardation Protein.

Potential Pharmacological Treatment of Fragile X Syndrome During Adulthood

Caveolin-1-Mediated Cholesterol Accumulation Contributes to Exaggerated Mglur-Dependent Long-Term Depression and Impaired Cognition in Fmr1 Knockout Mice.

Loss of FMRP Impaired Hippocampal Long-Term Plasticity and Spatial Learning in Rats.

Imbalance between Glutamate and GABA in Fmr1 Knockout Astrocytes Influences Neuronal Development